FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

FDA Asks Attention-Deficit Hyperactivity Disorder (ADHD)
Drug Manufacturers to Develop Patient Medication Guides

FDA has directed the manufacturers of all drug products approved for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) to develop patient Medication Guides to alert patients to possible cardiovascular risks and risks of adverse psychiatric symptoms associated with the medicines, and to advise them of precautions that can be taken.

Drugs

Note: This page links to PDF files which require the free Adobe Acrobat Reader.

Adderall (mixed salts of a single entity amphetamine product) Tablets Medication Guide Label
Adderall XR (mixed salts of a single entity amphetamine product) Extended-Release Capsules Medication Guide Label
Concerta (methylphenidate hydrochloride) Extended-Release Tablets Medication Guide Label
Daytrana (methylphenidate) Transdermal System Medication Guide Label
Desoxyn (methamphetamine hydrochloride) Tablets Medication Guide Label
Dexedrine (dextroamphetamine sulfate) Spansule Capsules and Tablets Medication Guide Label
Focalin (dexmethylphenidate hydrochloride) Tablets Medication Guide Label
Focalin XR (dexmethylphenidate hydrochloride) Extended-Release Capsules Medication Guide Label
Metadate CD (methylphenidate hydrochloride) Extended-Release Capsules Medication Guide Label
Methylin (methylphenidate hydrochloride) Oral Solution Medication Guide Label
Methylin (methylphenidate hydrochloride) Chewable Tablets Medication Guide Label
Ritalin (methylphenidate hydrochloride) Tablets Medication Guide Label
Ritalin SR (methylphenidate hydrochloride) Sustained-Release Tablets Medication Guide Label
Ritalin LA (methylphenidate hydrochloride) Extended-Release Capsules Medication Guide Label
Strattera (atomoxetine hydrochloride) Capsules Medication Guide Label

to top arrow Back to Top     back arrow Back to Drug Information

Date created: February 21, 2007, Updated September 21, 2007

horizonal rule